Monthly information regarding the total number of voting rights and total number of shares of the Company as of September 30, 2021
Monthly information regarding the total number of voting rights and total number of shares of…
Month: October 2021
Neuronetics Announces Preliminary Revenue for Third Quarter 2021
MALVERN, Pa., Oct. 12, 2021 (GLOBE NEWSWIRE) — Neuronetics, Inc. (NASDAQ: STIM), a commercial-stage medical…
Satsuma Pharmaceuticals Announces the Appointment of Mutya Harsch to its Board of Directors
SOUTH SAN FRANCISCO, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
Adicet Announces Promotion of Blake Aftab, Ph.D. to Chief Scientific Officer
MENLO PARK, Calif. and BOSTON, Oct. 12, 2021 (GLOBE NEWSWIRE) — Adicet Bio, Inc. (Nasdaq:…
Evaxion Biotech to Present Work on AI-Immunology Core Technology at Immuno UK 2021
COPENHAGEN, Denmark, Oct. 12, 2021 (GLOBE NEWSWIRE) — Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion” or…
Morphic to Participate in Jefferies IBD Therapeutics Summit
WALTHAM, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Morphic Therapeutic (Nasdaq: MORF), a biotechnology company…
Homology Medicines Announces World’s First Gene Editing Clinical Trial for PKU
– IND Clearance of pheEDIT Study to Evaluate a One-Time Dose of Investigational HMI-103 Incorporating…
Rezolute Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants, and a Concurrent Registered Direct Offering
REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Rezolute, Inc. (Nasdaq: RZLT) (“Rezolute” or…
Seer to Report Third Quarter Financial Results on November 9, 2021
REDWOOD CITY, Calif., Oct. 12, 2021 (GLOBE NEWSWIRE) — Seer, Inc. (Nasdaq: SEER), a life…
CRISPR Therapeutics Reports Positive Results from its Phase 1 CARBON Trial of CTX110™ in Relapsed or Refractory CD19+ B-cell malignancies
-58% overall response rate (ORR) and 38% complete response (CR) rate in large B-cell lymphoma…
Prometheus Biosciences to Present at Jefferies Virtual Next Generation IBD Therapeutics Summit
SAN DIEGO, Oct. 12, 2021 (GLOBE NEWSWIRE) — Prometheus Biosciences, Inc. (Nasdaq: RXDX), today announced…
EyePoint Pharmaceuticals Presents Preliminary Safety Data from Phase 1 DAVIO Trial and YUTIQ® CALM Registry Study at American Society of Retina Specialists (ASRS) 39th Annual Meeting
– 3-month safety data from DAVIO trial continues to demonstrate EYP-1901 is well-tolerated in eyes…
About the received documents
Joint Stock Company “Olainfarm”, hereinafter – the Company, has received from Black Duck Invest a.s….
Skye Bioscience Establishes New Cannabinoid Pharmaceutical Innovation Program
Exclusive sponsored research agreement with endocannabinoid research pioneers SAN DIEGO, CA, Oct. 12, 2021 (GLOBE…
Ultimovacs ASA: Share capital increase related to exercise of options
Oslo, 12 October 2021, the Board of Directors of Ultimovacs ASA (the “Company”) has resolved…
Evelyn D’An Joins Cytovia Therapeutics as Chief Financial Officer
Key leadership addition to support operational growth and drive company preparedness towards IPO AVENTURA, Fla.,…
Outlook Therapeutics’ Positive NORSE THREE Safety Data Presented at 2021 American Society of Retina Specialists for ONS-5010 Ophthalmic Bevacizumab
Strong safety data from NORSE THREE registration trial consistent with other trials for ONS-5010 and in…
EUROBIO Scientific : 2021 HALF-YEAR EARNINGS
2021 HALF-YEAR EARNINGS EBITDA up +110% to €42.5mNet cash of €60.4mCOVID accelerating the Group’s longstanding…
AGTC to Present at Upcoming Cell & Gene Meeting on the Mesa
GAINESVILLE, Fla. and CAMBRIDGE, Mass., Oct. 12, 2021 (GLOBE NEWSWIRE) — Applied Genetic Technologies Corporation (Nasdaq: AGTC),…
Rakovina Therapeutics Presents at the 2021 AACR-NCI-EORTC Virtual International Conference on Molecular Targets and Cancer Therapeutics
Presentation highlights pre-clinical data from Rakovina Therapeutics’ novel kt-3000 series dual PARP-HDAC inhibitors VANCOUVER, British…